• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低T3综合征对新诊断多发性骨髓瘤患者预后的影响

[The impact of low T3 syndrome on the prognosis of patients with newly diagnosed multiple myeloma].

作者信息

Zhang J, Zhang L N, Xia Y, Jin Y Y, Shen X X, Chen L J

机构信息

Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):216-221. doi: 10.3760/cma.j.issn.0253-2727.2023.03.007.

DOI:10.3760/cma.j.issn.0253-2727.2023.03.007
PMID:37356983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10119724/
Abstract

This study aimed to examine the relationship between low T3 syndrome (LT3S) and the prognosis of newly diagnosed multiple myeloma (NDMM) patients. A retrospective examination of 211 NDMM patients treated at the Department of Hematology, Jiangsu Provincial People's Hospital from July 2009 to December 2020 was performed, and all patients received thyroid function testing to determine if they had LT3S. We investigated the relationship between LT3S and clinical features, as well as its impact on MM prognosis. Of the 211 patients, 119 were males, and 92 were females, with a median age of 60 (33-86) years. Patients with LT3S had significantly higher levels of β(2)-microglobulin, C-reactive protein, and blood creatinine compared to those with normal T3 levels. They also had lower levels of hemoglobin, platelets, and serum albumin, as well as more advanced ISS stages (<0.001) . Patients with LT3S had shorter progression-free survival (PFS) (16 months 30 months, =0.003) and overall survival (OS) (57 months 75 months, =0.004) than patients without LT3S. LT3S was found to be a standalone unfavorable factor in multivariate analysis, LT3S was an independent unfavorable factor in predicting both PFS (=2.114, 95% 1.271-3.516, =0.004) and OS (=2.231, 95% 1.088-4.577, =0.029) . Low T3 syndrome was an independent unfavorable prognostic predictor for NDMM.

摘要

本研究旨在探讨低T3综合征(LT3S)与新诊断的多发性骨髓瘤(NDMM)患者预后之间的关系。对2009年7月至2020年12月在江苏省人民医院血液科接受治疗的211例NDMM患者进行了回顾性研究,所有患者均接受甲状腺功能检测以确定是否患有LT3S。我们调查了LT3S与临床特征之间的关系,以及其对MM预后的影响。211例患者中,男性119例,女性92例,中位年龄为60(33 - 86)岁。与T3水平正常的患者相比,LT3S患者的β2-微球蛋白、C反应蛋白和血肌酐水平显著更高。他们的血红蛋白、血小板和血清白蛋白水平也更低,国际分期系统(ISS)分期更晚(<0.001)。与无LT3S的患者相比,LT3S患者的无进展生存期(PFS)更短(16个月对30个月,P = 0.003),总生存期(OS)也更短(57个月对75个月,P = 0.004)。在多因素分析中,LT3S被发现是一个独立的不良因素,LT3S是预测PFS(P = 2.114,95%CI 1.271 - 3.516,P = 0.004)和OS(P = 2.231,95%CI 1.088 - 4.577,P = 0.029)的独立不良因素。低T3综合征是NDMM的独立不良预后预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/1f58d3f7b62e/cjh-44-03-216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/9284f22af2a4/cjh-44-03-216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/1915efe623a5/cjh-44-03-216-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/1f58d3f7b62e/cjh-44-03-216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/9284f22af2a4/cjh-44-03-216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/1915efe623a5/cjh-44-03-216-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec8/10119724/1f58d3f7b62e/cjh-44-03-216-g003.jpg

相似文献

1
[The impact of low T3 syndrome on the prognosis of patients with newly diagnosed multiple myeloma].低T3综合征对新诊断多发性骨髓瘤患者预后的影响
Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):216-221. doi: 10.3760/cma.j.issn.0253-2727.2023.03.007.
2
[Clinical features and prognosis of low triiodothyronine syndrome in patients with acute myeloid leukemia].[急性髓系白血病患者低三碘甲状腺原氨酸综合征的临床特征与预后]
Zhonghua Xue Ye Xue Za Zhi. 2021 Nov 14;42(11):923-929. doi: 10.3760/cma.j.issn.0253-2727.2021.11.007.
3
The Association Between Low T3 Syndrome and Survival in Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study.低 T3 综合征与新诊断多发性骨髓瘤患者生存的相关性:一项回顾性研究。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221094422. doi: 10.1177/15330338221094422.
4
Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction.低 T3 综合征可改善急性心肌梗死患者住院期间心血管死亡的风险预测。
J Cardiol. 2018 Sep;72(3):215-219. doi: 10.1016/j.jjcc.2018.02.013. Epub 2018 Mar 23.
5
Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.低 T3 综合征与 NT-proBNP 联合应用作为急性失代偿性心力衰竭患者死亡的预测因子。
BMC Endocr Disord. 2021 Jul 2;21(1):140. doi: 10.1186/s12902-021-00801-x.
6
[Clinical characteristics and prognosis of newly diagnosed multiple myeloma patients with FGFR3 gene mutations].[新诊断的伴有FGFR3基因突变的多发性骨髓瘤患者的临床特征与预后]
Zhonghua Xue Ye Xue Za Zhi. 2023 Dec 14;44(12):989-994. doi: 10.3760/cma.j.issn.0253-2727.2023.12.004.
7
[Analysis of clinical and prognostic characteristics of newly diagnosed multiple myeloma with myelofibrosis patients].[新诊断的伴有骨髓纤维化的多发性骨髓瘤患者的临床及预后特征分析]
Zhonghua Yi Xue Za Zhi. 2024 Jan 2;104(1):57-62. doi: 10.3760/cma.j.cn112137-20230713-00005.
8
[Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma].国际分期系统第二次修订版(R2-ISS)在新诊断多发性骨髓瘤预后评估中的应用
Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):170-177. doi: 10.3760/cma.j.cn121090-20230810-00058.
9
An analysis of perinatal factors of low T3 syndrome in preterm neonates with a gestational age of 28-35 weeks.分析 28-35 孕周早产儿低 T3 综合征的围生期因素。
Ann Med. 2021 Dec;53(1):1722-1726. doi: 10.1080/07853890.2021.1985731.
10
[Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].[CD56表达在新诊断多发性骨髓瘤患者中的预后价值及其相关因素]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):777-782. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.023.

本文引用的文献

1
The Association Between Low T3 Syndrome and Survival in Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study.低 T3 综合征与新诊断多发性骨髓瘤患者生存的相关性:一项回顾性研究。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221094422. doi: 10.1177/15330338221094422.
2
Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.低 T3 综合征与 NT-proBNP 联合应用作为急性失代偿性心力衰竭患者死亡的预测因子。
BMC Endocr Disord. 2021 Jul 2;21(1):140. doi: 10.1186/s12902-021-00801-x.
3
Prevalence and Incidence of Multiple Myeloma in Urban Area in China: A National Population-Based Analysis.
中国城市地区多发性骨髓瘤的患病率和发病率:一项基于全国人口的分析。
Front Oncol. 2020 Jan 24;9:1513. doi: 10.3389/fonc.2019.01513. eCollection 2019.
4
Mortality of lymphoma and myeloma in China, 2004-2017: an observational study.中国 2004-2017 年淋巴瘤和骨髓瘤的死亡率:一项观察性研究。
J Hematol Oncol. 2019 Mar 4;12(1):22. doi: 10.1186/s13045-019-0706-9.
5
Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.低 T3 综合征可作为慢性淋巴细胞白血病不良预后的预测指标。
Int J Cancer. 2018 Aug 1;143(3):466-477. doi: 10.1002/ijc.31327. Epub 2018 Mar 2.
6
Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma.低T3综合征是弥漫性大B细胞淋巴瘤的一个强有力的预后预测指标。
Br J Haematol. 2017 Apr;177(1):95-105. doi: 10.1111/bjh.14528. Epub 2017 Feb 1.
7
Prevalence and Clinical Significance of Low T3 Syndrome in Non-Dialysis Patients with Chronic Kidney Disease.非透析慢性肾脏病患者低T3综合征的患病率及临床意义
Med Sci Monit. 2016 Apr 8;22:1171-9. doi: 10.12659/msm.895953.
8
Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia.低T3综合征是社区获得性肺炎患者预后不良的有力预测指标。
Sci Rep. 2016 Mar 1;6:22271. doi: 10.1038/srep22271.
9
Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes.2型糖尿病慢性心力衰竭患者的游离三碘甲状腺原氨酸水平与短期预后
Am J Med Sci. 2015 Aug;350(2):87-94. doi: 10.1097/MAJ.0000000000000524.
10
Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders.甲状腺激素的神经保护作用及低T3综合征作为急性脑血管疾病生物标志物的研究
Expert Rev Neurother. 2015 Mar;15(3):315-26. doi: 10.1586/14737175.2015.1013465. Epub 2015 Feb 11.